Clinical Trials
3 trialsNCT03334617 2025-10-27
HUDSON
AstraZeneca
Phase 2 Active not recruiting
NCT00243347 2013-10-17
The Effects of AZD2171 in Patients With Non-Small Cell Lung Cancer or Head & Neck Cancer
AstraZeneca
Phase 1 Completed
NCT00539331 2011-06-01
Phase I/II Study of AZD2171 in Combination With Paclitaxel/Carboplatin in Japanese Non-Small Cell Lung Cancer Patients
AstraZeneca
Phase 1 Terminated